StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Net Sales YoY Growth Drivers Bridge by Quarter

Net Sales YoY Growth Drivers Bridge (% cc, % USD & percentage point contribution) (%)

QuarterlyAnnual

Novartis Net Sales YoY Growth Drivers Bridge: 4.0% in Q3 2026, down 3.0 pts from a year earlier.

Latest, Q3 2026
4.0%
Period ended Sep 30, 2026
Change on a year earlier
-3.0 pts
7.0% in Q3 2025
History
26 quarters
Since Q2 2020
Sources
26
Documents cited below

Where the Q3 2026 figure comes from

“|| Total net sales to third parties | 14 522 | 13 909 | 4 | 4”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Parent line represents constant currency net sales growth (% cc); child lines break down percentage point contributions from volume, price, generic competition, and exchange rates

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNet Sales YoY Growth Drivers Bridge (% cc, % USD & percentage point contribution) (%)Year on yearSource
Q3 2026Sep 30, 20264.0%-3.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20261.0%-10.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 2026-5.0%-20.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 2025-1.0%-17.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20257.0%-3.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 202511.0%0.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 202515.0%+4.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 202416.0%+6.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 202410.0%-2.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 202411.0%+3.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 202411.0%+3.0 ptsNovartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 202310.0%+6.0 ptsNovartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 202312.0%+7.0 ptsNovartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 20238.0%+3.0 ptsNovartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 20238.0%+3.0 ptsNovartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 20224.0%0.0 ptsNovartis Form 6-K (0001370368-23-000008) ↗

Breakdown

What makes up net Sales YoY Growth Drivers Bridge

Cite this data

StockData. (2026). Novartis Net Sales YoY Growth Drivers Bridge (%), quarterly Q2 2020–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/net-sales-growth-bridge

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.